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Background: Atherosclerosis constitutes the leading contributor to morbidity and mortality in cardiovascular and
cerebrovascular diseases. Lipid deposition and inflammatory response are the crucial triggers for the development
of atherosclerosis. Recently, microRNAs (miRNAs) have drawn more attention due to their prominent function on
inflammatory process and lipid accumulation in cardiovascular and cerebrovascular disease. Here, we investigated
the involvement of miR-21 in lipopolysaccharide (LPS)-induced lipid accumulation and inflammatory response in
macrophages.
Methods: After stimulation with the indicated times and doses of LPS, miR-21 mRNA levels were analyzed by
Quantitative real-time PCR. Following transfection with miR-21 or anti-miR-21 inhibitor, lipid deposition and
foam cell formation was detected by high-performance liquid chromatography (HPLC) and Oil-red O staining.
Furthermore, the inflammatory cytokines interleukin 6 (IL-6) and interleukin 10 (IL-10) were evaluated by Enzyme-linked
immunosorbent assay (ELISA) assay. The underlying molecular mechanism was also investigated.
Results: In this study, LPS induced miR-21 expression in macrophages in a time- and dose-dependent manner. Further
analysis confirmed that overexpression of miR-21 by transfection with miR-21 mimics notably attenuated lipid
accumulation and lipid-laden foam cell formation in LPS-stimulated macrophages, which was reversely up-regulated
when silencing miR-21 expression via anti-miR-21 inhibitor transfection, indicating a reverse regulator of miR-21 in
LPS-induced foam cell formation. Further mechanism assays suggested that miR-21 regulated lipid accumulation by
Toll-like receptor 4 (TLR4) and nuclear factor-κB (NF-κB) pathway as pretreatment with anti-TLR4 antibody or a specific
inhibitor of NF-κB (PDTC) strikingly dampened miR-21 silence-induced lipid deposition. Additionally, overexpression
of miR-21 significantly abrogated the inflammatory cytokines secretion of IL-6 and increased IL-10 levels, the
corresponding changes were also observed when silencing miR-21 expression, which was impeded by preconditioning
with TLR4 antibody or PDTC.
Conclusions: Taken together, these results corroborated that miR-21 could negatively regulate LPS-induced lipid
accumulation and inflammatory responses in macrophages by the TLR4-NF-κB pathway. Accordingly, our research will
provide a prominent insight into how miR-21 reversely abrogates bacterial infection-induced pathological processes of
atherosclerosis, indicating a promising therapeutic prospect for the prevention and treatment of atherosclerosis by
miR-21 overexpression.
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Atherosclerosis and its complications rank as the leading
cause of death, representing nearly 29% of mortalities
globally [1]. The large atherosclerotic plaque formation
and subsequent rupture is the crucial mechanism under-
lying the onset of acute ischemic syndromes, including
cerebral infarction, stroke, myocardial infarction, and
sudden death [2-4]. It is commonly accepted that lipid-
laden foam cell accumulation and inflammation in vessel
walls are the hallmarks of the early stage of athero-
sclerosis, and then trigger a series of atherosclerotic
complications [5].
Lipid deposition is the characteristic of atherosclerosis,
and then forms the lipid core and earliest detected
lesion, the fatty streak. It is known that the increasing
macrophage foam cell formation induces the production
of a large lipid-rich necrotic core, followed by the rup-
ture of vulnerable plaque and subsequent thrombogen-
esis, a key trigger for acute cardiovascular diseases [6].
Blocking lipid deposition dramatically dampens athero-
sclerotic coronary lesions, indicating a potential target
for atherosclerosis and cardiovascular events by the de-
crease of lipid levels [7,8].
Macrophages are believed to possess a pivotal function
in lipid-laden foam cell formation and inflammation dur-
ing atherosclerosis progression and plaque destabilization
[9,10]. It is well known that macrophages can be ac-
tivated by lipopolysaccharide (LPS) to uptake oxidized
low-density lipoprotein (ox-LDL), which is a necessary
step for macrophage foam cell production and the subse-
quent fatty streak formation. As a component of Gram-
negative bacteria cell walls, LPS has been gradually
demonstrated to be associated with cardiovascular disease
[11-13]. When injection with endotoxin LPS in apolipo-
protein E (apoE) deficient mice, the atherosclerotic lesion
size is significantly increased [12,14]. Importantly, LPS can
induce macrophage inflammation response and secrete
abundant pro-inflammatory cytokines, which aggravate
the atherosclerosis progress and lead to the instability
of vulnerable plaques. Chronic administration of LPS in
ApoE−/− mice obviously increases the production of in-
flammatory cytokines (such as TNF-α, IL-1β, IL-6, and
MCP-1) and enhances the development of atherosclerosis
[14]. Treatment with melittin dramatically recovers LPS-
induced atherosclerotic lesions by the suppression of
pro-inflammatory cytokines and adhesion molecules, sug-
gesting an important anti-atherogenic strategy [15].
MicroRNAs (miRNAs) are known to be highly con-
served, small non-coding RNA molecules (approximately
18–24 nucleotides), and represent a new class of gene
regulators, which can interact with the 3’-untranslated
region (3’-UTR) of a target gene to inversely regulate their
target gene transcription or translation. Emerging evi-
dences have demonstrated that miRNAs exert prominentroles in the inflammatory process and lipid accumulation
in patients with coronary artery disease [16-18]. For ex-
ample, miR-147 can act as a negative feedback regulator
for Toll like receptor 4 (TLR4)-induced inflammatory re-
sponses [19]. Among these members, more researches
have been focused on miR-21 as its significant roles in
heart, tissue injury, inflammation, and cardiovascular dis-
eases [20-22]. Recent research has confirmed a notable up-
regulation of miR-21 in atherosclerotic plaques, indicating
a pivotal effect on plaque destabilization [23]. However, the
function of miR-21 in the progress of atherosclerosis and
vulnerable plaques remains unknown.
In this study, we aimed to explore the effects of miR-21
on LPS-induced lipid accumulation and inflammation
responses in macrophages. Furthermore, the underlying
mechanism involved in this process was also discussed.
Material and methods
Reagents and antibodies
LPS (Escherichia coli, 055:B5) was obtained from Sigma
(St. Louis, MO). Primary antibodies including antibodies
against TLR4 and NF-κB p65 were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). The corresponding
horseradish peroxidase-conjugated secondary antibodies
were from Calbiochem (La Jolla, CA). NF-κB inhibitor
PDTC was from Sigma Chemical Co. (St. Louis, MO).
Cell culture and treatment
Mouse RAW 264.7 monocyte/macrophage-like cell line
was purchased from the American Type Culture Collec-
tion (ATCC, Manassas, VA). Cells were cultured at 37°C
under 5% CO2 in DMEM supplemented with 10% FCS
and 100 U/mL streptomycin-penicillin. Before stimula-
tion with the indicated dose and times of LPS, cells were
stimulated with anti-TLR4 antibody (10 μg/ml), or 30 μM
NF-κB inhibitor PDTC for 4 h, prior to incubation with
ox-LDL (50 μg/ml). Cells from the third to fifth passage
were used in this experiment.
Transfection
To specifically induce miR-21 expression in macro-
phages, the miRIDIAN™ miR-21 mimics was introduced.
The miRIDIAN™ hairpin inhibitor was used to effect-
ively silence the endogenous mature miR-21 function.
The miR-2 mimics, scrambled control microRNA, anti-
miR-210 inhibitor and anti-microRNA control inhibitor
were obtained from Thermo Scientific (Lafayette, CO).
For transfection, 0.4 nmol microRNA mimics or anti-
microRNA inhibitors was mixed with 15 μl Geneporter 2
Transfection Reagent (GTS, San Diego), and were then
transfected into 1 × 106 cells for 6 h. After incubation
with fresh medium for 48 h, cells were used for further
experiments. miR-21 overexpression and inhibition were
assessed using quantitative PCR.
Feng et al. Lipids in Health and Disease 2014, 13:27 Page 3 of 9
http://www.lipidworld.com/content/13/1/27RNA extraction and quantitative real-time PCR
After stimulation with LPS, the total RNA from cells was
isolated using the mirVana™ miRNA isolation kit accord-
ing to the manufacturer’s instructions (Roche Diagnostics,
Mannheim, Germany). To quantify the expression levels
of miR-21 in cultured and transfected cells, TaqMan
miRNA assay kits (Applied Biosystems, Foster City, CA)
were introduced. Briefly, the obtained RNA was reverse-
transcribed to synthesize the complementary DNA with
the Oligo (dT) primer (Fermentas). Then, a sepcific pri-
mer for miR-21 and sno202 was obtained from Ambion to
perform the TaqMan assays according to the manufac-
turers’ protocol. Additionally, sno202 was introduced as a
normalizing control. The relative expression was calcu-
lated using 2-ΔΔCT.
Oil red O staining
After stimulation with LPS (100 ng/ml) and ox-LDL for
24 h, the cultured and transfected macrophages were
washed with PBS three times, following fixation with
4% paraformaldehyde/PBS for 15 min. Then, cells were
rinsed with ddH2O, and then the neutral lipids were
stained using the freshly diluted 0.5% Oil red O solution
(Sigma) for 10 min at 37°C. Cells were then rinsed with
water, and hematoxylin was introduced to label the cell
nuclei. The Oil red O-stained lipids in macrophage-
derived foam cells were morphologically evaluated by
microscopy.
Lipid assay by high-performance liquid chromatography
(HPLC)
The cellular lipids (total cholesterol, TC; cholesterol
ester, CE) were analyzed as previously described [24].
Briefly, cells were rinsed with PBS for three times, and
then lysed with 0.9% NaOH solution followed by homo-
genization in ice bath for 10 s. The BCA kit was used
to evaluate the protein concentration, an equal volume
of trichloroacetic acid was introduced and centrifuged
for 10 min. Using stigmasterol to construct a standard
curve first, and then the extraction procedure was re-
peated. Then, the samples were re-suspended in 100 μl of
isopropanol-acetonitrile (v/v, 20:80) for 5 min. Ultimately,
all the samples were placed on Agilent 1100 series HPLC
(Wilmington, DE).
Western blotting
Following rinses with PBS three times, the total protein
extracts of RAW 246.7 cells were extracted using RIPA
lysis buffer (Beyotime, Nantong, China), following the
quantitative analysis of protein concentrations via the BCA
assay (Pierce, Rockford, IL). For western blotting, the ob-
tained protein was electrophoresed by SDS-polyacrylamide
gel electrophoresis, and about 100 μg of protein was
then transferred onto a polyvinylidene difluoride (PVDF)membrane in a semi-dry transblot apparatus. After incuba-
tion with buffer containing 5% nonfat dry milk in Tris-
buffered saline with Tween (TBST) at 4°C overnight, the
PVDF membrane was cultured with anti-TLR4 and anti-
p65 NF-κB antibodies for 1 h at 37°C to probe the targeted
protein. Following washed three times with TBST, HRP-
conjugated secondary antibodies were added for 1 h. The
LumiGLo reagent (KPL, Gaithersburg, MD) was used to
visualize the bound antibodies. The protein expression
levels were normalized by β-actin.
Enzyme-linked immunosorbent assay (ELISA) assay
To analyze the levels of interleukin 6 (IL-6) and interleu-
kin 10 (IL-10) in the transfected macrophages stimulated
with LPS, the ELISA assay was introduced. Briefly, about
2 × 105 cells were seeded into 24 well plates and incu-
bated at 4°C overnight. The transfected cells were stimu-
lated with LPS for 24 h, and the concentrations of IL-6
and IL-10 in supernatants were measured using ELISA
DuoSet Development systems according to the manufac-
turer’s instructions (R&D Systems).
Statistical analysis
All assays were performed in triplicate and numerical
results were presented as mean ± SEM. SPSS 11.0 was
used to analyze the data. The statistical significance of
differences between groups was analyzed by Student
t-test. A p value less than 0.05 was considered statistically
significant.
Results
LPS induced miR-21 expression in macrophages
LPS is known to be critical for the progress of athero-
sclerotic plaques [13]. To assess the expression levels
of miR-21 in LPS-induced macrophages, qRT-PCR was
performed. As shown in Figure 1A, an obvious up-
regulation of miR-21 mRNA levels was observed at 8 h
post LPS stimulation. Simultaneously, treatment with
inchmeal increased times of LPS stimulation, the mRNA
levels of miR-21 were gradually up-regulated, indicating
that LPS triggered a time-dependent increase in the ex-
pression levels of miR-21 mRNA in macrophages. After
exposure to various doses of LPS (0, 50 and 100 ng/ml),
the mRNA levels of miR-21 were about 3.4-fold and
6-fold over control at 50 ng/ml- and 100 ng/ml-treated
groups, respectively (Figure 1B). Taken together, these re-
sults confirmed that LPS could trigger the expression of
miR-21 in macrophages in a dose- and time-dependent
manner.
MiR-21 negatively regulated LPS-induced macrophage
foam cell formation
Numerous reports have been confirmed that LPS can
enhance the ability of macrophages to become foam cells,
Figure 1 LPS-induced expression of miR-21 in macrophages.
After stimulation with the indicated times (A) and doses (B) of LPS,
the mRNA levels of miR-21 in macrophages were detected by
quantitative RT-PCR. *P < 0.05 versus control group. **P < 0.01.
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vestigate the function of miR-21 in LPS-induced foam cell
formation, we overexpressed and silenced the expression
levels of miR-21 in macrophages. After transfection with
miR-21 mimics, a dramatic increase in miR-21 mRNA was
observed in macrophages compared with the control group
(Figure 2A). Moreover, anti-miR-21 inhibitor notably re-
duced the expression levels of miR-21 mRNA (Figure 2B).
To further analyze the roles of miR-21 in LPS-induced
lipid accumulation in macrophages, we performed the
HPLC assay. As shown in Figure 2C, overexpression of
miR-21 prominently attenuated LPS-induced lipid depos-
ition, and the ratio of CE/TC decreased from 49.82%
to 26.86%. Furthermore, silencing miR-21 mRNA levels
through transfection with anti-miR-21 inhibitor, remark-
ably accelerated LPS-induced ratio of CE/TC. Additionally,
Oil red O staining analysis suggested that overexpression
of miR-21 obviously dampened LPS-triggered macrophage
uptake of ox-LDL, and abrogated the formation of lipid
droplets (Figure 2D). A corresponding increase in foam cell
formation was also determined in anti-miR-21 inhibitors-
transfected macrophages. Together, these results suggested
that miR-21 overexpression inhibited LPS-induced foam
cell formation, which was reversely enhanced when miR-
21 mRNA levels were silenced in LPS-stimulated macro-
phages, indicating as a negative regulator of miR-21 in
LPS-triggered macrophage foam cell formation.TLR4-NF-κB pathway was responsible for miR-21-
mediated lipid deposition in LPS-stimulated macrophage
As a common receptor of LPS, TLR4 and its down-
stream signaling effector NF-κB are crucial for atheroscler-
otic plaque formation and coronary lesion progression
[26,27]. To clarify the mechanism underlying miR-21-
regulated lipid accumulation in macrophages, TLR4 and
NF-κB pathway was introduced. Western blotting analysis
ascertained that transfection with miR-21 mimics strikingly
impeded the expression levels of TLR4, as well as intra-
nuclear NF-κB p65 levels (Figure 3A). Consistently, down-
regulation of miR-21 expression significantly increased the
activation of TLR4 in LPS-induced macrophages, con-
comitant with the activation of intra-nuclear NF-κB
p65. Together, our data indicated that miR-21 could
dampen LPS-induced activation of TLR4-NF-κB pathway
in macrophages.
To further assess the correlation between miR-21-
regulated TLR4 signaling and lipid accumulation in
LPS-induced macrophage, we silenced the TLR4-NF-κB
pathway. As shown in Figure 3B, pretreatment with spe-
cific anti-TLR4 antibody dramatically abrogated TLR4
expression. Simultaneously, a significant inhibition of
NF-κB activation was also manifested by preconditioning
with the NF-κB inhibitor PDTC (Figure 3C). Further
mechanism assays corroborated that anti-miR-21 inhibi-
tor transfection significantly accelerated lipid deposition
in LPS-stimulated macrophages, which was prominently
attenuated by pretreatment with anti-TLR4 antibody,
indicating that miR-21 silencing enhanced lipid accu-
mulation by LPS-activated TLR4 pathway (Figure 3D).
Moreover, a similar decrease in lipid accumulation was
validated in PDTC-treated groups. Taken together, these
results told that miR-21 majorly regulated lipid-laden
macrophage foam cell formation stimulated with LPS via
TLR4-NF-κB pathway.
miR-21 mediated the production of inflammatory
cytokines by TLR4-NF-kB in LPS-induced macrophages
During the progression of atherosclerotic plaques, the
release of critical pro-inflammatory cytokines from mac-
rophages such as IL-6, IL-12 and TNF-α, was considered
to be pivotal [5,14]. To further assess the effects of
miR-21 on LPS-induced inflammatory response in mac-
rophages, we assessed the inflammation cytokine levels
of IL-6 and IL-10 by ELISA assay. As shown in Figure 4A,
LPS dramatically induced the production of IL-6 levels,
and this increase was significantly decreased by miR-21
mimics transfection in macrophages. Furthermore, the
levels of anti-inflammatory cytokine IL-10 was obviously
enhanced compared to LPS-treated groups. Consistently,
the inhibition of miR-21 expression with anti-miR-21
inhibitor transfection notably augmented IL-6 levels
(Figure 4B), as well as an obvious decrease in IL-10 levels
Figure 2 Effect of miR-21 on lipid-laden foam cell formation in LPS-stimulated macrophages. To investigate the function of miR-21 on
LPS-induced lipid accumulation, cells were respectively transfected with miR-21 mimics, scrambled control microRNA, anti-miR-210 inhibitor and
anti-microRNA control inhibitor for 6 h. (A) Overexpression of miR-21 in miR-21 transfected cells. *P < 0.05 versus control microRNA group.
(B) Down-regulation of miR-21 in macrophages. *P < 0.05 versus anti-microRNA control inhibitor group. (C-D) After exposure to ox-LDL (μg/ml)
for 24 h, the ratio of CE/TC and foam cell formation was assessed by HPLC assay (C) and Oil red O staining (D). *P < 0.05.
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miR-21 down-regulated the pro-inflammatory cytokine
IL-6 levels and up-regulated the anti-inflammatory cyto-
kine IL-10 levels, indicating an important function on in-
flammatory response in macrophage-stimulated by LPS.
The activation of TLR-4 induces the production of in-
flammation cytokines to regulate the immune responses,which is a prominent contributor to atherosclerotic
plaque formation and instability by the LPS/TLR4 signal
transduction pathway [28,29]. To further clarify the
underlying mechanism involved in miR-21-regulated
macrophage inflammatory response, TLR-4 signaling was
included. After silencing the activation of TLR-4 by specific
antibody, the expression levels of IL-6 were strikingly
Figure 3 miR-21 inhibited lipid accumulation by TLR4-NF-κB pathway. (A) After overexpressed or silenced the expression levels of miR-21,
the activation of TLR4 and intra-nuclear NF-κB p65 was demonstrated by western blotting analysis. (B-C) Before stimulation with 100 ng/ml LPS
for 24 h, cells were stimulated with anti-TLR4 antibody (10 μg/ml), or 30 μM NF-κB inhibitor PDTC for 4 h. The silencing effect of TLR4 (B) and
intra-nuclear NF-κB p65 (C) was evaluated. (D) The association between miR-21 and the TLR4-NF-κB pathway was analyzed by western blotting. *P < 0.05.
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phages (Figure 4D). Moreover, blocking the activation of
TLR-4 downstream effector NF-κB with PDTC, IL-6 levels
was significantly impended in LPS and anti-miR-21-
treated groups. For IL-10, its expression was correspond-
ingly increased after preconditioning with TLR-4 specific
antibody and NF-κB inhibitor PDTC, compared with LPS
stimulation plus con-Amb and DMSO. Taken together,
our data suggested that miR-21 could regulate inflamma-
tion response in macrophage stimulated by LPS via sup-
pressing TLR-4-NF-κB signaling.
Discussion
Cardiovascular disease has garnered increased interest
and became the pre-eminent health problem worldwide as
the leading cause of death and illness [1,3]. Atherosclerosisconstitutes the single most crucial contributor to the out-
come of cardiovascular diseases. Recently, numerous ani-
mal and cell experiments have focused on the miRNA
profile in atherosclerotic processes, and an obvious up-
regulation of miR-21 has been demonstrated in athero-
sclerotic plaques [23,30]. However, its function on the
developmental progress of atherosclerotic plaques re-
mains unclear. In this study, our results have manifested
that miR-21 levels were significantly increased, and can
negatively regulate lipid accumulation and inflammation
cytokine secretion in LPS-stimulated macrophages by
TLR-4-dependent signaling.
LPS, as one of the best studied immunostimulatory
components of bacteria, has been proven to enhance
lipid deposition and lipid-derived macrophage foam cell
formation, as well as inflammatory cytokines release. All
Figure 4 miR-21 regulated the secretion of inflammatory cytokines in LPS-induced macrophages. (A) Following transfection with miR-21,
levels of IL-6 and IL-10 was detected by ELISA assay. *P < 0.05 versus LPS-untreated group. #P < 0.05 versus LPS plus miR-con group. (B-C) The
effect of miR-21 silencing on IL-6 and IL-10 levels in macrophages exposed to 100 ng/ml LPS. (D) Cells were pretreatment with anti-TLR4 antibody
(10 μg/ml) or 30 μM NF-κB inhibitor PDTC for 4 h, and then LPS-induced IL-6 and IL-10 levels were detected in anti-miR-21 inhibitor-transfected
cells. *P < 0.05.
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can regulate the pathological process of atheroscler-
osis and its complications. In this study, LPS dose-
and time-dependently induced the expression of miR-21
mRNA. To clarify the roles of miR-21 in atherosclerosis,
we analyzed the effect of miR-21 in LPS-induced lipidaccumulation and inflammatory response in macrophages.
After transfection with miR-21 mimics, the overexpression
of miR-21 was induced in macrophages, and the corre-
sponding down-regulation of it was also performed by
anti-miR-21 inhibitor transfection. Lipid-laden foam cell
formation is a critical trigger for the development of
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dramatically attenuated the ratio of CE/TC, indicating an
obvious decrease in lipid accumulation in LPS-stimulated
macrophages. Simultaneously, blocking of miR-21 ex-
pression accelerated LPS-induced lipid deposition in
macrophages. Further analysis suggested that a notable
reduction in foam cell formation was observed when
overexpression of miR-21 in macrophages exposed to
LPS. While in contrast to the control group, inhibiting
miR-21 expression induced dramatically lipid droplets
formation in macrophages stimulated with LPS. To-
gether, our results suggested that miR-21 negatively regu-
lated LPS-induced lipid accumulation in macrophages.
Toll-like receptors (TLRs) exerts multiple roles in ath-
erosclerosis, and is highly expressed in atherosclerotic
plaque. Among these members, TLR4 has drawn more
attention during the development progress of athero-
sclerosis. TLR4 is known as the receptor of LPS, and its
deficiency significantly attenuated aortic atherosclerosis
in ApoE−/− mice [31]. Moreover, lipid accumulation
in circulating monocytes was significantly reduced in
TLR4-deficient mice. Growing evidence indicates that
TLR4 plays a very important role in macrophage foam
cells formation, indicating a critical roles of TLR4 in ath-
erosclerosis via regulating lipid deposition [32,33]. To
elucidate the underlying mechanism involved in miR-21-
regulated lipid-laden macrophage foam cell formation,
TLR4 pathway was discussed. As expected, miR-21 over-
expression remarkably dampened the activation of TLR4
and its downstream NF-κB, while miR-21 expression
inhibition reversely augmented the activation of TLR4-
NF-κB. When blocking TLR4 expression with its spe-
cific antibody, LPS-induced lipid accumulation was
strikingly decreased in macrophages transfected with
anti-miR-21 inhibitor. Simultaneously, a similar reduc-
tion in lipid deposition was also confirmed when pre-
treatment with PDTC. Hence, these results suggested
that miR-21 could negatively regulated lipid accumula-
tion via TLR4-NF-κB pathway in LPS-stimulated macro-
phages, implying an important role in the development
of atherosclerosis.
During the past decade, a prominent role for in-
flammation in atherosclerosis and its implications have
been appreciated. Inflammation ranks as a major charac-
terization for atherosclerosis, and the release of abundant
inflammatory molecules will give rise to abnormal foam
cell formation and initiate the development of athero-
sclerotic lesions. Blocking macrophage inflammation
by TGR5 activation attenuates atherosclerosis lesions, indi-
cating a potential therapeutic aspect in anti-atherosclerosis
[34]. LPS is known as a potent inducer of the inflam-
matory response. Therefore, we further analyzed the
effect of miR-21 in LPS-triggered inflammation in macro-
phages. Following transfection with miR-21, the levels ofpro-inflammatory cytokine IL-6 was dramatically attenu-
ated, accompany with an increase of anti-inflammatory
cytokine IL-10. The corresponding changes of IL-6 and
IL-10 were also confirmed when silencing miR-21 levels,
indicating an important function of miR-21 on LPS-
induced macrophage inflammation. As a key component
of innate immune response, TLR4 possesses a pivotal role
in the initiation and progression of atherosclerosis, and can
regulate the inflammatory response in macrophages via its
downstream NF-κB signaling [29,35]. To further elucidate
the underlying mechanism involved in miR-21-mediated
inflammation cytokines secretion, we blocked the activa-
tion of TLR4 and NF-κB. After blocking TLR4 expression,
the increase in IL-6 and decrease in IL-10 was significantly
mitigated in miR-21-silencing cells. The similar changes in
IL-6 and IL-10 were also corroborated when precondition-
ing with PDTC in anti-miR-21 inhibitor-transfected mac-
rophages. Together, these results told that miR-21 could
regulate macrophage inflammation and lipid accumulation
via the TLR4- NF-κB signaling pathway. However, the
mechanism involved in miR-21-induced inhibitory effect
on TLR4-NF-κB is still unclear, which needs to be explored
in our next plan.
In conclusion, our research investigated for a potential
role of miR-21 in atherosclerosis. In this study, LPS
induced the expression of miR-21 in a time- and dose-
dependent manner. Further analysis manifested that miR-
21 negatively regulated lipid-laden foam cell formation and
inflammatory responses in LPS-stimulated macrophages
through the TLR4-NF-κB pathway, indicating a critical
roles of miR-21 in the progression of atherosclerosis.
Hence, the beneficial clinical effects of miR-21 overexpres-
sion in the prevention and treatment of atherosclerosis
deserve further investigations.
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